Skip to content

Computerized Cardiotocography Monitoring of Fetuses With pPROM

Computerized Cardiotocography Monitoring in Fetuses With Preterm Premature Rupture of Membranes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04632017
Acronym
COCA-PROM
Enrollment
40
Registered
2020-11-17
Start date
2020-06-15
Completion date
2021-07-30
Last updated
2020-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiotocography, Premature Birth, Premature Rupture of Membrane, Rupture of Membranes; Premature, Sepsis

Keywords

cardiotocography, Premature Rupture of Membrane, computerized cardiotocography, premature birth

Brief summary

Preterm premature rupture of membranes (PPROM) is associated with neonatal complications leading to a high rate of cerebral palsy, sepsis, and death. Choosing the best time of delivery is crucial to improve fetal outcome. The balance is between a premature delivery exposing the infant to all the risk of prematurity, and keeping the baby in utero, prolonging the exposure to an adverse intrauterine milieu. There are no objective and reproducible tools to help in this decision-making process. Techniques most frequently used for fetal surveillance are biased by high inter- and intra-observer variability. Computerized cardiotocography (cCTG) identifies several objective parameters related to fetal heart rate (FHR) to determine fetal well-being. cCTG has been successfully used in fetuses with intrauterine growth restriction, but it has never been used in prospective studies to assess its role in the management of fetuses with PPROM. The investigators designed a case control study to highlight cCTG differences in PPROM pregnancies versus physiological pregnancies, to establish the effectiveness in predicting adverse outcome, and to develop a score to predict neonatal outcome.

Detailed description

Preterm premature rupture of membranes (PPROM) occurs in 2 to 3% of pregnancies and is associated with higher maternal and neonatal morbidity and mortality. Neonatal complications are primarily due to prematurity and to ascending infection of the amniotic cavity (chorioamnionitis), leading to a high rate of cerebral palsy, intracranial hemorrhage, sepsis, pneumonia, and death. Every physician is confronted with an extremely difficult and at the same time of paramount importance decision, when it comes to establish the timing of the delivery of a premature fetus with PPROM. The balance is between delivering a premature infant exposed to all the risk of prematurity, and keeping the baby in utero, prolonging the exposure to an adverse intrauterine milieu. At present, there are no objective and reproducible tools to help in this decision-making process. The technique most frequently used for fetal surveillance is cardiotocography (CTG). Assessment of the fetal heart rate is classified subjectively as 'reassuring' or 'not reassuring'. Dawes and Redman have suggested computerized CTG (cCTG), which eliminates inter- and intra-observer variability, identifying several objective parameters to determine fetal well-being. After the multicentre TRUFFLE-Study, cCTG became the best tool to manage fetuses with intrauterine growth restriction (IUGR). However, the use of cCTG has never been investigated in prospective studies to assess its role in the management of fetuses with PPROM. Of note, amniotic fluid concentration of glucose, lactate, interleukin-6 (IL-6), and matrix metalloproteinase-8 (MMP-8) have been associated with neonatal septicemia, chorioamnionitis, preterm birth, and/or fetal inflammatory response syndrome in women with pPROM.

Interventions

To compare Dawes and Redman indices as determined by computer analysis of the fetal heart tracing

Sponsors

University of Campania Luigi Vanvitelli
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years

Inclusion criteria

* pPROM between 24 and 34 weeks (w)

Exclusion criteria

* multiple pregnancy, structural fetal anomalies, preexisting or gestational diabetes mellitus and\\or hypertension, intrauterine growth restriction.

Design outcomes

Primary

MeasureTime frame
Preterm birth rateLess than 37 weeks gestation

Secondary

MeasureTime frameDescription
Preterm birth ratesLess than 24, 28, 34 weeks gestation
Birth weightTime of deliveryWeight of the baby at the time of delivery
Low birth weight rateTime of deliveryBirth weight \<2500g
Gestational age at deliveryTime of delivery
Composite adverse neonatal outcomesBetween birth and 28 days of ageNumber of neonates who will have at least one of the following: necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death
Maternal outcomesBetween birth and 28 days after the birthNumber of mothers who will have at least one of the following: sepsis, histological chorioamnionitis, hysterectomy, intensive care unit admission.
Dawes and Redman indicesbetween 24 and 34 weeks of gestationdetermined by computer analysis of the fetal heart tracing
Neonatal death rateBetween birth and 28 days of age

Countries

Italy

Contacts

Primary ContactMaddalena Morlando, MD
madmorlando@gmail.com+39 333 426 3110
Backup ContactFabiana Savoia, MD
dott.fabianasavoia@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026